Oncology Information Systems - Global Strategic Business Report

Global Oncology Information Systems Market to Reach $5.7 Billion by 2030

The global market for Oncology Information Systems estimated at US$3.6 Billion in the year 2022, is projected to reach a revised size of US$5.7 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030. Software, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$4.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 3.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 5.8% CAGR

The Oncology Information Systems market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$994.7 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Select Competitors (Total 43 Featured) -

• Accuray, Inc.
• Cerner Corporation
• Elekta AB
• Epic Systems Corporation
• Flatiron Health, Inc.
• Koninklijke Philips NV
• McKesson Corporation
• RAYSEARCH Laboratories AB
• Varian Medical Systems, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year